The main purpose of this review is to summarize recent chemical syntheses and structural modifications of 4-hydroxycoumarin and its derivatives, of interest due to their characteristic conjugated molecular architecture and biological activities.
Introduction
4-Hydroxycoumarins (2H-1-benzopyran-2-ones, Figure 1 ) have evoked a great deal of interest due to their biological properties and characteristic conjugated molecular architecture. Many of them display important pharmacological effects, including analgesic [1] , anti-arthritis [2] , anti-inflammatory [3] , anti-pyretic [4] , anti-bacterial [5] , anti-viral [6] , and anti-cancer [7] properties. 4-Hydroxycoumarin and its derivatives have been effectively used as anticoagulants for the treatment of disorders in which there is excessive or undesirable clotting, such as thrombophlebitis [8] , pulmonary embolism [9] , and certain cardiac conditions [10] . A number of comparative pharmacological investigations of the 4-hydroxycoumarin derivatives have shown good anticoagulant activity combined with low side effects and little toxicity [11] . Nowadays 4-hydroxycoumarin and its derivatives are widely used anticoagulant rodenticides as well as antithrombotic agents [12] . The 4-hydroxycoumarin anticoagulants are antagonists of vitamin K and their target is vitamin K 2,3-epoxide reductase in the liver microsomes. Finally, they are also useful key intermediates for many industrial products such as dyes [13] and liquid crystals [14] .
The chemical synthesis, structural modification, and a wide variety of biological activities of 4-hydroxycoumarins have been reported in many papers [15] [16] [17] . The goal of this review is to summarize recent synthetic approaches to 4-hydroxycoumarin derivatives and their biological activities.
Results and Discussion
The 2H-1-benzopyran-2-one and tetrahydronaphthalen-1-ols skeletons are essential structural features in the second generation rodenticide 4-hydroxycoumarin derivatives. They have traditionally been coupled in acidic media. Although several improved condensation reactions of 4-hydroxycoumarin (1) with compounds 8-9 using Bronsted-Lowry acids (HCl, H 2 SO 4 , p-TsOH) have been reported [18] [19] [20] [21] , these reactions led to preferential dehydrohalogenation, resulting in low yields. Thus, an efficient coupling condition was required to obtain better yield. Scheme 1 shows a representative retrosynthetic approach for this class of molecules. The tetrahydronaphthalen-1-ol 8 was coupled with 4-hydroxycoumarin (1) or 4-hydroxythiocoumarin (2) to generate the target 2H-1-benzopyran-2-one or 2H-1-benzothiopyran-2-one. 
+
Our previous synthesis of flocoumafen (5) [18] [19] is summarized in Scheme 2. Its main reactions were Friedel-Crafts acylation, Reformatsky reaction, and dehydration. Commercially available phenylacetyl chloride (10) was condensed with anisole (11) in the presence of AlCl 3 to afford ketone 12, which was treated with ethyl bromoacetate to give hydroxyl ethyl ester 13 in 86% yield over two steps. Subsequent dehydroxylation of ethyl ester 13 was accomplished with triethylsilane and boron trifluoride to give the corresponding ester, which was smoothly hydrolyzed under basic conditions and cyclized using polyphosphoric acid to yield tetralone 14 in three steps. Reduction of tetralone 14 with sodium borohydride afforded secondary alcohol 15, which was then coupled with 4-hydroxycoumarin in the presence of p-toluenesulfonic acid to give compound 16. Demethylation of compound 16 was performed with hyrobromic acid in acetic acid to give phenol 17. Phenol 17 was O-alkylated with freshly prepared 3-(trifluoromethyl)benzyl bromide in sodium hydride/THF to generate flocoumafen (5) in good yield (overall yield was 25% in eight steps).
The Ferreira group [20] has developed to a new protocol for the synthesis of diphenacoum (29) and brodifacoum (30) . The key step involves the stereospecific formation of one of the crucial bonds in the molecular backbone using asymmetric organocopper 1,4-addition to chiral imides. Wittig condensation of freshly prepared aldehydes 18, 19, and (carbethoxy)triphenylphosphonium chloride (20) in the presence of sodium methoxide in DMF gave the biphenyl esters 21, 22 in 92% and 87% yield, respectively. Organocopper methodology was then successfully applied to the synthesis of butanoate. 1,4-Michael addition with compounds 21, 22 and BnCu-TMEDA complex in the presence of TMS-Cl generated 23, 24 in 84% and 81% yield, respectively, and then subsequent ring cyclization by using AlCl 3 in toluene to give tetralones 25 and 26 in 88% and 86% yield, respectively. The coupling reaction between 4-hydroxycoumarin 1 and secondary alcohol 27 or brominated compound 28 under an HCl atmosphere at 160 °C 30 min provided approximately equal quantities of the cis and trans isomers of 4-hydroxycoumarin derivatives 29 and 30 in 78% and 74% yield, respectively (Scheme 3). The Yang group [21] reported the synthesis of novel diphenacoum analogues using base-catalyzed aldol condensation, ring cyclization, and coupling reactions. 2-Hydroxyacetophenone (31) was treated with aldehydes 32 or 33 under base-catalyzed aldol reaction conditions to produce ketones 34, 35, which were readily cyclized by phosphoric acid in ethanol to give 2-biphenylchroman-4-ones 36 and 37, respectively. Reduction of 36 and 37 with sodium borohydride in methanol gave quantitative yields of the corresponding alcohols 38 and 39, which were then condensed with 4-hydroxycoumarin (1) in 1,2-dichloroethane in the presence of a catalytic amounts of p-toluenesulfonic acid, to yield the target compounds 40 and 41, respectively (Scheme 4). The Danchev group [22] reported a synthesis of 4-hydroxcoumarin derivatives and their anticoagulant activities. Their method involves a condensation reaction of 4-hydroxcoumarin (1) with unsaturated ketone 42 or substituted aromatic aldehydes 32-33 (Scheme 5). Warfarin type compound 43 showed similar anticoagulant effect as coumachlor or warfarin in vivo, while its acute toxicity was higher than that of woumachlor. Among their 4-hydroxcoumarin derivatives 3,3'-(4-chlorophenylmethylene)-bis-(4-hydroxy-2H-1-benzopyran-2-one), with low toxicity, is a prospective lead compound. On the other hand, the Raghunathan group [24] successfully established a pyrano [3-2c] coumarin framework using microwave accelerated intramolecular domino Knoevenagel-hetero Diels-Alder reactions. 4-Hydroxycoumarin (1) was treated with 2-(3-methyl-2-butenyloxy)benzaldehyde under microwave irradiation in ethanol for 15 s to give a 97:3 ratio of pyrano [3-2c] coumarin 51 and pyrano[3-2c]chromene derivative 52 in good yield (Scheme 7). This methodology is very useful, providing an easy access to the pyrano [3-2c] coumarin skeleton found in many natural products. The Swenson group [27] recently published a unique procedure for preparation of 3-(p-azido, amino, and nitrobenzyl)-4-hydroxycoumarins 62-64 by the reaction of freshly prepared benzyl malonic acid 60 and phenol (61) in the presence of phosphorus trichloride and zinc chloride (Scheme 9). They also prepared various radiolabeled 3-substituted 4-hydroxycoumarin derivatives using commercially available [U- 14 Recently, stereoselective synthesis has been an important topic in the synthesis of biologically active substances. Efficient asymmetric syntheses of 4-hydroxycoumarin derivatives were demonstrated by two groups. The Ferreira group [30] firstly reported a highly stereo-and enantioselective synthesis of diphenacoum (29) and brodifacoum (30) . The key step involves a stereospecific 1,4-Michael addition using a chiral auxiliary and intramolecular ring cyclization. The esters 21, 22 were transformed into acid chlorides through hydrolysis and chlorination with KOH and SOCl 2 , and subsequently reacted with the lithium anion of the chiral auxiliary to afford the chiral imides 65-68 in 72%, 74%, 73%, and 70% yield, respectively, for three steps. Asymmetric 1,4-Michael addition of imides 65-68 was accomplished with Bn-Cu-TMEDA complex in the presence of Bu 2 BOTf to give diastereoisomeric ketones 69-72, which were effectively cyclized using trifluoromethanesulfonic acid to generate chiral tetralones 73-76 with 99% optical purity in 85%, 84%, 79%, and 80% yield, respectively. Reduction of tetralones 73-76 with sodium borohydride afforded the corresponding cis benzyl alcohols, which were condensed with 4-hydroxcoumarin (1) to give cis/trans diphenacoum and brodifacoum, respectively (Scheme 10). The stereoisomeric mixtures were readily separated by flash column chromatography. The configuration was established using spectroscopic analysis.
Scheme 10. Stereo-and enantioselective synthesis of diphenacoum (29) and brodifacoum (30) . The Jorgensen group [31] reported a highly economical organocatalytic asymmetric 1,4-Michael addition of 4-hydroxycoumarin and α,β-unsaturated ketones to generate the widely used anticoagulants warfarin (Coumadin) and some related important compounds (Scheme 11). They attempted enantioselective 1,4-Michael addition by using well known benzylideneacetophenone (85) and 4-hydroxycoumarin (1) in the presence of optically active imidazolidine catalysts 86-88 to afford enantiopure warfarin moieties with 47 to 82% ee values in 22 to 96% yields. This asymmetric one-step method could be useful for the formation of a number of biologically active compounds. The Tagliapietra group [32] developed an asymmetric two-step synthesis of non-racemic coumarin anticoagulants such like warfarin, coumachlor, and acenocoumarol through one-pot-three-component tandem Knoevenagel-hetero Diels-Alder cycloaddition reactions between in situ generated 3-arylidene-2,4-chromanediones 89 and isopropenyl ether 90 derived from (-)-menthol in 61% yield with 95% ee for (S)-warfarin, 56% yield with 93% ee for (S)-coumachlor, and 59% yield with 95% ee for (S)-acenocoumarol (Scheme 12). Knoevenagel adducts 91 were treated with 3N-HCl in the presence of SiO 2 
Biological Activity
A large number of 4-hydroxycoumarins and their derivatives have been synthesized and evaluated for their ability to play a positive role in the prevention of human and animal diseases. Various pharmacological activities for the representative compounds have been described in the literature (Table 1) . Most 4-hydroxycoumarin derivatives showed representative anticoagulant effects, while compounds 3, 5, 30, 40, 46, and 64 exhibit a wide variety of activities including antiarthritis, antiinflammatory, anticancer, antithrombosis, teratogenic, antibacterial, and photoaffinity effects. [47] Anticoagulant is the most prominent among many intriguing pharmacological effects observed for many 4-hydroxycoumarin derivatives. In particular warfarin, as first generation anticoagulant, and compounds like brodifacoum, bromadiolone, chlorophacinone, difenacoum, coumatetralyl, flocoumafen, and difethialone are effective anticoagulant rodenticides. The second generation anticoagulant rodenticides, difenacoum (29) and brodifacoum (30) showed a plasma elimination halflife of 91.7 days, while liver elimination half-lives varied from 15.8 days for coumatetralyl (4) to 307.4 days for brodifacoum. In general, the elimination half-lives in plasma for first-generation rodenticides were shorter than those for second-generation rodenticides. These results revealed that the so-called superwarfarins such as difenacoum (29) , brodifacoum (30), flocoumafen (5) , and difethialone (6) showed higher anticoagulant effects than warfarin [48] . The biological activities of compounds 40 and 41 indicate potent vitamin K 2,3-epoxide reductase (VKOR) inhibition effects with IC 50 values of 0.4 μM, comparable with warfarin. Compound 40 was shown to be 2.5-fold more potent than warfarin, while compound 41 exhibited 10 times less activity than warfarin. These biological results imply that the hydrogen bonding has a major effect on enzyme site binding [21] . 4-Hydroxycoumarin derivatives 43 showed favorable anticoagulant effect compared with warfarin; especially a chlorine at the para-position in the aromatic ring resulted in potent anticoagulant activities compared to nitro or other halogen substituents at the para-position [22, 49] . The dicoumarol related compounds 48-49 were evaluated for antimicrobial, antioxidant activities using MIC tests and radical scavenging activities. Also, compounds 48 and 49 showed favorable antimicrobial activity compared to warfarin and similar effects to each other for the antioxidant activity. In addition, the coumarol moiety showed more potent activity than a benzopyranocoumarol moiety due to the stable configuration and favorable binding activity through hydrogen bonding in the enzyme binding site [22] . 6-Bromo-4-hydroxycoumarin (54) and 4-hydroxy-6,7-benzocoumarin (56) exhibited significant anticoagulant effect with a rapid short duration. Especially 3,3'-alkylidene bis-6-bromo-4-hydroxycoumarin derivatives showed a potent anticoagulant activity in vitro [25] .
A 4-hydroxycoumarin containing an azidobenzyl group at the 3-position − 3-(p-azidobenzyl)-4-hydroxycoumarin (64)-showed an inhibition constant of 6.6 × 10 -8 M, a value comparable to that observed for dicoumarol (1.7 × 10 -9 M), but significantly lower than that for warfarin (3.5 × 10 -5 M).
This result implies that compound 64 can be an effective photoaffinity probe in the identification of other proteins associated with the vitamin K-dependent carboxylation system that are similarly inhibited by 4-hydroxycoumarin derivatives [46] .
Conclusions
The chemical syntheses and structural modifications of 4-hydroxycoumarin and its derivatives are of interest due to their biological activities and characteristic conjugated molecular architecture. This review summarized the recent synthetic approaches to 4-hydroxycoumarin derivatives and the current state of research into their biological activities.
